Board
David Whelan
Director
David Whelan is the Chief Executive of the Cloverleaf Group, a privately held alternative investment firm which is primarily focussed on venture capital investment opportunities in the healthcare, life sciences and technology sectors. David is a non-executive director of the following Cloverleaf Group portfolio companies: AgaMatrix Inc, Clear Play International Limited, Mu-Gahat Holdings Inc, MD Datacor Inc. and Medcenter Holdings, Inc. Prior to joining the Cloverleaf Group, David was Vice President of Corporate Development at the Virgin Group in the US and was previously an investment banker in London, England and Sydney, Australia with Goldman Sachs & Company and before that Deutsche Bank. David has a Bachelor of Laws (Honours) and Bachelor of Commerce from Bond University in Queensland, Australia.
